Glucose containing solution
Showing 1 - 25 of >10,000
Gastric Emptying Trial in Vienna (Intervention #1: ProvideXtra Drink, Intervention #2: Fresubin Energy Drink, Intervention #3:
Completed
- Gastric Emptying
- Intervention #1: ProvideXtra Drink
- +2 more
-
Vienna, AustriaMedical University Vienna
Aug 11, 2022
End Stage Renal Disease Trial in Chieti (1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, 0.7% Xylitol, 0.5% Glucose, and
Recruiting
- End Stage Renal Disease
- 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
- 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
-
Chieti, ItalyDepartment of Nephrology, University of Chieti
Aug 20, 2021
Gastroenteritis Acute Trial (Glucose containing Oral Rehydration Solution (ORS), Sugar free - amino acid and electrolyte ORS)
Not yet recruiting
- Gastroenteritis Acute
- Glucose containing Oral Rehydration Solution (ORS)
- Sugar free - amino acid and electrolyte ORS
- (no location specified)
Feb 17, 2022
Food Preferences, Appetitive Behavior Trial (Conditioned Stimulus: Sucrose (aim 1), Conditioned Stimulus: Glucose (aim 1),
Not yet recruiting
- Food Preferences
- Appetitive Behavior
- Conditioned Stimulus: Sucrose (aim 1)
- +5 more
- (no location specified)
Aug 24, 2023
End Stage Renal Disease (ESRD) Trial (Icodextrin, xylitol and carnitine solution for peritoneal dialysis, EXTRANEAL 7.5G/100Ml
Not yet recruiting
- End Stage Renal Disease (ESRD)
- Icodextrin, xylitol and carnitine solution for peritoneal dialysis
- EXTRANEAL 7.5G/100Ml Peritoneal Dialysis Solution
- (no location specified)
Mar 28, 2022
Glucose Response, Glycemic Index, Insulin Response Trial in Udine (consumption of glucose solution 1, consumption of glucose
Active, not recruiting
- Glucose Response
- +3 more
- consumption of glucose solution 1
- +4 more
-
Udine, ItalyDepartment of Agricultural, Food, Environmental and Animal Scien
Nov 28, 2023
Glucose Intolerance Trial in Canfield (Active, Placebo)
Completed
- Glucose Intolerance
- Active
- Placebo
-
Canfield, OhioThe Center for Applied Health Sciences
Jun 1, 2023
Myalgia, Muscle Pain, Orofacial Pain Trial in Wroclaw (An aqueous solution containing CBD and CBN, The aqueous solution of )
Not yet recruiting
- Myalgia
- +5 more
- An aqueous solution containing CBD and CBN
- The aqueous solution of placebo
-
Wroclaw, PolandWroclaw Medical University
Jul 16, 2023
SARS-CoV2 Infection Trial in Larissa (Hypertonic seawater solution)
Completed
- SARS-CoV2 Infection
- Hypertonic seawater solution
-
Larissa, Thessaly, GreeceUniversity Hospital of Larissa
Feb 15, 2023
Acute Heart Failure, Congestion, Heart Failure Trial in Wroclaw (Furosemide intravenous infusion, Continous intravenous infusion
Recruiting
- Acute Heart Failure
- +2 more
- Furosemide intravenous infusion
- +2 more
-
Wroclaw, Lower Silesia, PolandInstitute of Heart Diseases, Wroclaw Medical University
Jul 23, 2023
Postprandial Hypoglycemia Trial (First concept product (containing 50 grams of carbohydrates), Second concept product
Not yet recruiting
- Postprandial Hypoglycemia
- First concept product (containing 50 grams of carbohydrates)
- +2 more
- (no location specified)
Dec 22, 2022
Glucose Intolerance, Diabetes, Type 2, Healthy Diet Trial in Dublin (Sucrose solution, Seaweed extract in sucrose solution)
Recruiting
- Glucose Intolerance
- +3 more
- Sucrose solution
- Seaweed extract in sucrose solution
-
Dublin, Dublin 2, IrelandInstitute of Food and Health Volunteer Suite; Science Center Sou
Jul 15, 2022
Acute Pancreatitis in Type 2 Diabetes Mellitus Treated With
Active, not recruiting
- Diabetes Mellitus, Type 2
- empagliflozin
- Oral non-incretin/non-sodium glucose co-transporter-2 inhibitors (SGLT2)-containing hypoglycaemic agents
-
Ingelheim am Rhein, GermanyBoehringer Ingelheim International GmbH
Aug 19, 2022
Type 2 Diabetes Trial (Connected Solution with H2S app which connects with blood glucose meter (BGM))
Not yet recruiting
- Type 2 Diabetes Mellitus
- Connected Solution with H2S app which connects with blood glucose meter (BGM)
- (no location specified)
Jan 12, 2023
Potential Abnormality of Glucose Tolerance, Appetitive Behavior, Blood Pressure Trial in Athens (Glucose as reference food,
Completed
- Potential Abnormality of Glucose Tolerance
- +2 more
- Glucose as reference food
- +3 more
-
Athens, GreeceAgricultural University of Athens
Jul 30, 2022
Gestational Diabetes Trial in Chiayi City (oral glucose tolerance test using water at room temperature, oral glucose tolerance
Completed
- Gestational Diabetes Mellitus
- oral glucose tolerance test using water at room temperature
- +7 more
-
Chiayi City, TaiwanDitmanson Medical Foundation Chia-Yi Christian Hospital
Aug 17, 2022
Potential Abnormality of Glucose Tolerance, Appetitive Behavior, Blood Pressure Trial in Athens (Glucose as reference food,
Completed
- Potential Abnormality of Glucose Tolerance
- +2 more
- Glucose as reference food
- +3 more
-
Athens, Attica, GreeceAgricultural University of Athens
Jul 30, 2022
Blood Pressure Trial in Sherbrooke (BHB supplement, Placebo solution)
Not yet recruiting
- Blood Pressure
- BHB supplement
- Placebo solution
-
Sherbrooke, Quebec, CanadaCentre de recherche sur le vieillissement
Apr 6, 2023
Obstructive Sleep Apnea, Complication, Pain Trial in Shijiazhuang (honeysuckle and semen oroxyli solution)
Completed
- Obstructive Sleep Apnea
- +2 more
- honeysuckle and semen oroxyli solution
-
Shijiazhuang, Hebei, ChinaHebei Hospital of traditional Chinese Medicine
Sep 8, 2022
Anesthesia, General Anesthesia, Analgesics, Opioid Trial in Saskatoon (Acetaminophen, Gabapentin, Lidocaine 1% Injectable
Recruiting
- Anesthesia
- +10 more
- Acetaminophen, Gabapentin
- +5 more
-
Saskatoon, Saskatchewan, CanadaRoyal University Hospital
Oct 31, 2022
Central Line-associated Bloodstream Infection (CLABSI) Trial in Utrecht (TauroLock-Hep100 (taurolidine 1.35%, citrate 4%,
Recruiting
- Central Line-associated Bloodstream Infection (CLABSI)
- TauroLock-Hep100 (taurolidine 1.35%, citrate 4%, heparin 100 IU/mL)
- Heparin lock (heparin 100 IU/mL)
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 13, 2023
Patient Acceptance ofCommercially Available Beverage as Compared
Recruiting
- Cystic Fibrosis
- Cystic Fibrosis-related Diabetes
- OGTT
-
Amsterdam, Woubruggestraat 28-huis, NetherlandsAmsterdam UMC
May 12, 2022
Glycemic Control, Diet, Food and Nutrition Trial in Lund (Drinks containing 5AA+CrPic and Placebo)
Completed
- Glycemic Control
- Diet, Food and Nutrition
- Drinks containing 5AA+CrPic and Placebo
-
Lund, SwedenAventure AB
Nov 17, 2022
Blood Glucose Trial in Canfield (Placebo, Chromium)
Completed
- Blood Glucose
- Placebo
- Chromium
-
Canfield, OhioThe Center for Applied Health Sciences
Nov 6, 2022
SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Bangkok (Human IgG1 anti-SARS-CoV-2 antibody cocktail,
Completed
- SARS CoV 2 Infection
- SARS-CoV-2 Acute Respiratory Disease
- Human IgG1 anti-SARS-CoV-2 antibody cocktail
- Placebo
-
Bangkok, ThailandNational Cancer Institute of Thailand
Jul 5, 2022